When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different. Imagine ...
BOSTON, Sept 5 (Reuters) - Amgen Inc and Roche Holding AG laid out opening arguments on Wednesday in a trial that will determine whether Roche can sell its anemia drug Mircera in the United States to ...
Amgen Inc. said late Tuesday that a U.S. district court issued a final injunction that bars Swiss drug maker Roche Group from selling its anemia drug Mircera in the United States until 2014. The ...
Credit: Getty Images. Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. Vadadustat was found to be noninferior to a long-acting erythropoiesis-stimulating agent (ESA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results